IL93397A - Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens - Google Patents

Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens

Info

Publication number
IL93397A
IL93397A IL93397A IL9339790A IL93397A IL 93397 A IL93397 A IL 93397A IL 93397 A IL93397 A IL 93397A IL 9339790 A IL9339790 A IL 9339790A IL 93397 A IL93397 A IL 93397A
Authority
IL
Israel
Prior art keywords
islet cell
antigens
peptides
diagnosis
preparation
Prior art date
Application number
IL93397A
Other languages
English (en)
Other versions
IL93397A0 (en
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of IL93397A0 publication Critical patent/IL93397A0/xx
Publication of IL93397A publication Critical patent/IL93397A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL93397A 1989-02-17 1990-02-14 Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens IL93397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31254389A 1989-02-17 1989-02-17
US44170389A 1989-12-04 1989-12-04

Publications (2)

Publication Number Publication Date
IL93397A0 IL93397A0 (en) 1990-11-29
IL93397A true IL93397A (en) 1997-06-10

Family

ID=26978437

Family Applications (1)

Application Number Title Priority Date Filing Date
IL93397A IL93397A (en) 1989-02-17 1990-02-14 Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens

Country Status (14)

Country Link
EP (1) EP0383129B1 (fr)
JP (1) JP2858467B2 (fr)
AT (1) ATE122394T1 (fr)
AU (1) AU626636B2 (fr)
CA (1) CA2010275C (fr)
DE (1) DE69019190T2 (fr)
DK (1) DK0383129T3 (fr)
ES (1) ES2072928T3 (fr)
FI (1) FI103730B1 (fr)
GR (1) GR3017019T3 (fr)
IE (1) IE66997B1 (fr)
IL (1) IL93397A (fr)
NO (1) NO306996B1 (fr)
PT (1) PT93166B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645998A (en) * 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US6001360A (en) * 1988-12-13 1999-12-14 University Of Florida Method and compositions for early detection and treatment of insulin dependent diabetes mellitus
JPH02200700A (ja) * 1989-01-30 1990-08-08 Shionogi & Co Ltd 新規ｒｅｇ蛋白質
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
US5175085A (en) * 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
US5744327A (en) * 1990-02-20 1998-04-28 Board Of Regents, The University Of Texas System Methods for producing insulin in response to non-glucose secretagogues
EP0547164B1 (fr) 1990-09-07 2004-06-09 The Regents Of The University Of California Procedes de diagnostic et de traitement de diabete
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
US5998366A (en) * 1990-09-21 1999-12-07 The Regents Of The University Of California Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
US6682906B1 (en) 1990-09-21 2004-01-27 The Regents Of The University Of California Cloned glutamic acid decarboxylase
WO1992006105A1 (fr) * 1990-10-02 1992-04-16 Trigen Incorporated Anticorps et procedes de diagnostic et de traitement du diabete
JPH06508030A (ja) * 1991-05-15 1994-09-14 ザイモジェネティクス，インコーポレイティド ヒトすい島グルタミン酸デカルボキシラーゼ自己抗原のクローニング及び発現
US5792656A (en) * 1991-06-03 1998-08-11 Board Of Regents, The University Of Texas System Methods of preparing genetically engineered cells that produce insulin in response to glucose
WO1993016725A1 (fr) * 1992-02-27 1993-09-02 The Board Of Trustees Of The Leland Stanford Junior University Antigene precoce pour diabete autoimmun
US5200318A (en) * 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
WO1996038479A1 (fr) * 1995-05-30 1996-12-05 Fujisawa Pharmaceutical Co., Ltd. Procede de diagnostic du diabete sucre insulino-dependant et kit de diagnostic
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
CA2288343A1 (fr) * 1997-04-25 1998-11-05 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
CN110244051A (zh) * 2019-07-05 2019-09-17 许昌学院 一种用于糖尿病的多组分标记免疫检测系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0084796B1 (fr) * 1982-01-22 1990-05-02 Cetus Corporation Procédé pour la caractérisation de HLA et sondes de cADN pour sa mise en oeuvre
IL69686A (en) * 1983-09-11 1988-03-31 Yeda Res & Dev Compositions containing cell membrane proteins and process for their preparation
JP2614853B2 (ja) * 1985-06-14 1997-05-28 ジェネティック システムズ コーポレイション 増加した危機の糖尿病に関連する対立遺伝子を同定するための方法
CA1327162C (fr) * 1987-04-09 1994-02-22 Board Of Trustees Of The Leland Stanford Junior University (The) Methode de traitement prophylactique de personnes atteintes de maladies auto-immunes
JP2512796B2 (ja) * 1987-06-24 1996-07-03 オートイミュン・インコーポレイテッド 自己抗原の経口投与による自己免疫疾患の治療法

Also Published As

Publication number Publication date
IE66997B1 (en) 1996-02-21
NO900474L (no) 1990-08-20
AU626636B2 (en) 1992-08-06
DK0383129T3 (da) 1995-10-09
FI103730B (fi) 1999-08-31
DE69019190D1 (de) 1995-06-14
PT93166B (pt) 1997-11-28
ATE122394T1 (de) 1995-05-15
CA2010275A1 (fr) 1990-08-17
ES2072928T3 (es) 1995-08-01
EP0383129B1 (fr) 1995-05-10
DE69019190T2 (de) 1995-09-14
IE900589L (en) 1990-08-17
NO900474D0 (no) 1990-02-01
PT93166A (pt) 1990-08-31
GR3017019T3 (en) 1995-11-30
FI900759A0 (fi) 1990-02-15
IL93397A0 (en) 1990-11-29
CA2010275C (fr) 2000-08-29
JPH0347133A (ja) 1991-02-28
FI103730B1 (fi) 1999-08-31
EP0383129A2 (fr) 1990-08-22
EP0383129A3 (fr) 1991-07-31
AU4988390A (en) 1990-08-23
JP2858467B2 (ja) 1999-02-17
NO306996B1 (no) 2000-01-24

Similar Documents

Publication Publication Date Title
EP1092774A3 (fr) Antigène de Borrelia burgdorferi OspA, gène le codant et leur utilisations
CA2290485A1 (fr) Procede de production de proteines non immunogenes
AU626636B2 (en) Pancreatic islet cell antigens obtained by molecular cloning
EP0784059A4 (fr) Polypeptide antigenique de chlamydia pneumoniae
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
FI943591A7 (fi) Synteettinen hemofilus-influenssa yhdistelmärokote
WO1995029193A3 (fr) Antigenes du melanome
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
WO2000034317A3 (fr) Modification de l'immunogenicite de proteines
EP2145897A3 (fr) Procédés thérapeutiques et compositions basées sur des protéines serrate et acides nucléiques
WO1988009818A2 (fr) Recepteur d'hormone de croissance
IL95742A0 (en) Recombinant polypeptides and peptides,nucleic acids coding for the same and use of these polypeptides and peptides in the diagnosis of tuberculosis
AU3342397A (en) Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
PL319835A1 (en) Peptidic specificity of anti-basic myelinic protein and administration of basic myelinic protecin peptides to sm patients
GB9219936D0 (en) Vaccines
NZ333203A (en) Tumour antigen proteins, genes thereof, and tumour antigen peptides
AU6096090A (en) Mutants of human interleukin-3
WO1993019178A3 (fr) Peptides utilises pour l'induction de tolerance
KR920012440A (ko) 인간 인터류킨-5 수용체
KR960705583A (ko) Mhc 단백질의 원핵세포내 형질발현(prokaryotic expression of mhc proteins)
EP0770875A3 (fr) Marqueur et réactif pour diabète sucré et complication du diabète sucré
EP0293827A3 (fr) Essai pour leishmaniose
AU4712993A (en) New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods
NO944634L (no) Rekombinant timotei gresspollenallergen PhlpII
KR930703444A (ko) 어류 황체화 호르몬-방출 호르몬 동족체

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
EXP Patent expired